OptimizeRx Corporation
OPRX
$6.53
$0.101.56%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.78% | 24.18% | 25.90% | 20.66% | 28.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.78% | 24.18% | 25.90% | 20.66% | 28.81% |
| Cost of Revenue | 9.42% | 15.17% | 17.84% | 10.84% | 14.42% |
| Gross Profit | 23.94% | 29.57% | 30.84% | 26.95% | 38.41% |
| SG&A Expenses | -6.25% | 2.76% | 2.06% | 6.04% | 13.61% |
| Depreciation & Amortization | -0.07% | 2.36% | 20.56% | 44.91% | 80.15% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.75% | 7.02% | 8.13% | 8.99% | 15.77% |
| Operating Income | 301.91% | 192.10% | 138.47% | 72.65% | 54.80% |
| Income Before Tax | 135.85% | 105.06% | 64.56% | 36.28% | 22.87% |
| Income Tax Expenses | 150.62% | 118.04% | 106.77% | 90.25% | 109.58% |
| Earnings from Continuing Operations | 125.52% | 100.14% | 44.91% | 14.71% | -14.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 125.52% | 100.14% | 44.91% | 14.71% | -14.48% |
| EBIT | 301.91% | 192.10% | 138.47% | 72.65% | 54.80% |
| EBITDA | 1,096.29% | 417.73% | 224.68% | 115.39% | 84.79% |
| EPS Basic | 124.93% | 100.11% | 46.40% | 18.36% | -7.51% |
| Normalized Basic EPS | 161.08% | 115.03% | 88.27% | 34.32% | 9.78% |
| EPS Diluted | 123.08% | 99.69% | 46.28% | 18.67% | -6.97% |
| Normalized Diluted EPS | 157.88% | 114.31% | 87.94% | 34.32% | 9.78% |
| Average Basic Shares Outstanding | 1.43% | 2.00% | 4.07% | 5.60% | 6.82% |
| Average Diluted Shares Outstanding | 4.31% | 3.91% | 4.78% | 5.60% | 6.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |